Nanorobotic microgels to control stem cell fate
Developing innovative microgel technology with nanorobotics to enhance stem cell differentiation for improved cardiac regeneration in myocardial infarction patients.
Projectdetails
Introduction
Myocardial infarction continues to claim the lives of millions of people every year, and survivors are often left with severe health issues. Transplanting cardiac cells engineered from human stem cells into the injured heart is a particularly promising approach to repairing damaged cardiac tissue.
Problem Statement
Despite extensive research on stem cell-based therapies, a major limitation is effectively regulating stem cell differentiation. Mechanically training stem cells throughout culture could be a solution, by exploiting their mechanosensitive nature. However, there is currently a lack of technology that can recreate the mechanically dynamic microenvironment of tissue.
Project Aim
Therefore, I aim to develop an innovative cell culture technology, based on designer microgels and nanorobotics, which will allow control over stem cell differentiation.
Methodology
To achieve this goal, I will:
- Package pluripotent stem cells in smart microgels using microfluidics.
- Rigorously adjust material properties to ensure culture conditions that simulate the native tissue microenvironment.
- Utilize smart microgels with tunable stiffness to improve cardiogenic differentiation in pluripotent stem cells.
- Integrate wirelessly controlled nanoactuators to mechanically train stem cells to decipher the relationship between forces and stem cell differentiation.
Team Collaboration
Together with my team, I will develop rapid culture and stimulation methods based on microfluidics to identify the best conditions for stem cell preparation.
Conclusion
This multifunctional technology will contribute to achieving efficient cardiac regeneration and has great potential to make a big impact in regenerative medicine.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.500.000 |
Totale projectbegroting | € 1.500.000 |
Tijdlijn
Startdatum | 1-11-2024 |
Einddatum | 31-10-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- TECHNISCHE UNIVERSITAET MUENCHENpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Harnessing Novel Micropeptides in Cardiomyocytes to promote Cardiac RegenerationNovel.CaRe aims to enhance cardiac regeneration post-myocardial infarction by using micropeptides to stimulate cardiomyocyte proliferation and maturation through innovative gene therapy approaches. | ERC Starting... | € 1.592.281 | 2024 | Details |
3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughputHEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments. | ERC Consolid... | € 2.969.219 | 2022 | Details |
Restoring anisotropy in living tissues 'in situ'This project aims to enhance cardiac tissue regeneration by restoring structural anisotropy using ultrasound, improving therapy outcomes through a multidisciplinary and technology-driven approach. | ERC Advanced... | € 3.056.887 | 2022 | Details |
Engineering soft microdevices for the mechanical characterization and stimulation of microtissuesThis project aims to advance mechanobiology by developing soft robotic micro-devices to study and manipulate 3D tissue responses, enhancing understanding of cell behavior and potential cancer treatments. | ERC Advanced... | € 3.475.660 | 2025 | Details |
Surgical optogenetic bioprinting of engineered cardiac muscleLIGHTHEART aims to revolutionize heart failure treatment by developing a surgical bioprinting tool that uses optogenetics to create engineered cardiac muscle directly at the patient's heart. | ERC Starting... | € 1.499.705 | 2023 | Details |
Harnessing Novel Micropeptides in Cardiomyocytes to promote Cardiac Regeneration
Novel.CaRe aims to enhance cardiac regeneration post-myocardial infarction by using micropeptides to stimulate cardiomyocyte proliferation and maturation through innovative gene therapy approaches.
3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughput
HEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments.
Restoring anisotropy in living tissues 'in situ'
This project aims to enhance cardiac tissue regeneration by restoring structural anisotropy using ultrasound, improving therapy outcomes through a multidisciplinary and technology-driven approach.
Engineering soft microdevices for the mechanical characterization and stimulation of microtissues
This project aims to advance mechanobiology by developing soft robotic micro-devices to study and manipulate 3D tissue responses, enhancing understanding of cell behavior and potential cancer treatments.
Surgical optogenetic bioprinting of engineered cardiac muscle
LIGHTHEART aims to revolutionize heart failure treatment by developing a surgical bioprinting tool that uses optogenetics to create engineered cardiac muscle directly at the patient's heart.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Engineering a living human Mini-heart and a swimming Bio-robotThe project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease. | EIC Pathfinder | € 4.475.946 | 2022 | Details |
High-throughput ultrasound-based volumetric 3D printing for tissue engineeringSONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research. | EIC Pathfinder | € 2.999.625 | 2025 | Details |
Bringing 3D cardiac tissues to high throughput for drug discovery screensDeveloping a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability. | EIC Transition | € 1.457.500 | 2023 | Details |
Engineering a living human Mini-heart and a swimming Bio-robot
The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.
High-throughput ultrasound-based volumetric 3D printing for tissue engineering
SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.
Bringing 3D cardiac tissues to high throughput for drug discovery screens
Developing a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability.